Chinese
9
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight Loss
A Study on Association Between HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer
Correlation of Genetic Susceptibility Genes to Inflammatory Bowel Disease in Chinese Han Population
RF Based QIMT & QAS Study on Chinese Adults
Lexical Tone Perception in Tone language--a fMRI Study
Multicenter Observational Study of Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Rare Driver Gene Mutation
Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer
The Study of Molecular Risk Panels (70-gene Assay) in Chinese Breast Cancer Patients
The Living Experience of Hong Kong Chinese Adolescents With CHD.